Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Harvard Bioscience (HBIO) Shares Outstanding (Diluted Average) (2016 - 2019)

Historic Shares Outstanding (Diluted Average) for Harvard Bioscience (HBIO) over the last 11 years, with Q3 2019 value amounting to $38.0 million.

  • Harvard Bioscience's Shares Outstanding (Diluted Average) rose 294.8% to $38.0 million in Q3 2019 from the same period last year, while for Sep 2019 it was $38.0 million, marking a year-over-year increase of 294.8%. This contributed to the annual value of $36.5 million for FY2018, which is 489.1% up from last year.
  • As of Q3 2019, Harvard Bioscience's Shares Outstanding (Diluted Average) stood at $38.0 million, which was up 294.8% from $37.7 million recorded in Q2 2019.
  • In the past 5 years, Harvard Bioscience's Shares Outstanding (Diluted Average) registered a high of $38.0 million during Q3 2019, and its lowest value of $32.9 million during Q1 2015.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $34.8 million (2017), whereas its average is $35.2 million.
  • As far as peak fluctuations go, Harvard Bioscience's Shares Outstanding (Diluted Average) soared by 631.25% in 2015, and later plummeted by 256.53% in 2016.
  • Harvard Bioscience's Shares Outstanding (Diluted Average) (Quarter) stood at $33.6 million in 2015, then grew by 1.84% to $34.2 million in 2016, then rose by 1.58% to $34.8 million in 2017, then rose by 4.89% to $36.5 million in 2018, then grew by 4.34% to $38.0 million in 2019.
  • Its Shares Outstanding (Diluted Average) was $38.0 million in Q3 2019, compared to $37.7 million in Q2 2019 and $37.6 million in Q1 2019.